Publisher: Wiley-Blackwell on behalf of the International Society on Thrombosis and Haemostasis

Related content
Volume 9, Number 11, 1 November 2011

< previous issue | all issues | next issue >

Favourites:Add to Favourites

Free Content Management of patients with recently implanted coronary stents on dual antiplatelet therapy who need to undergo major surgery
pp. 2133-2142(10)
Authors: SAVONITTO, S.; CARACCIOLO, M.; CATTANEO, M.; DE SERVI, S.

Favourites:Add to Favourites

Free Content RNA‐based therapeutic approaches for coagulation factor deficiencies
pp. 2143-2152(10)
Authors: PINOTTI, M.; BERNARDI, F.; DAL MAS, A.; PAGANI, F.

Favourites:Add to Favourites

Free Content Comparison of enoxaparin and unfractionated heparin in endovascular interventions for the treatment of peripheral arterial occlusive disease: a randomized controlled trial
pp. 2159-2167(9)
Authors: DUSCHEK, N.; VAFAIE, M.; SKRINJAR, E.; HIRSCH, K.; WALDHÖR, T.; HÜBL, W.; BERGMAYR, W.; KNOEBL, P.; ASSADIAN, A.

Favourites:Add to Favourites

Free Content Population pharmacokinetic analysis of the oral thrombin inhibitor dabigatran etexilate in patients with non‐valvular atrial fibrillation from the RE‐LY trial
pp. 2168-2175(8)
Authors: LIESENFELD, K.‐H.; LEHR, T.; DANSIRIKUL, C.; REILLY, P. A.; CONNOLLY, S. J.; EZEKOWITZ, M. D.; YUSUF, S.; WALLENTIN, L.; HAERTTER, S.; STAAB, A.

Favourites:Add to Favourites

Free Content Concentrate‐related inhibitor risk: is a difference always real?
pp. 2176-2179(4)
Authors: IORIO, A.; MARCUCCI, M.; MAKRIS, M.

Favourites:Add to Favourites
Favourites:Add to Favourites

Free Content The timing, extent, progression and regression of deep vein thrombosis in immobile stroke patients: observational data from the CLOTS multicenter randomized trials
pp. 2193-2200(8)
Authors: DENNIS, M.; MORDI, N.; GRAHAM, C.; SANDERCOCK, P.; on behalf of the CLOTS trials collaborationcr5

Favourites:Add to Favourites

Free Content The effects of cause of death classification on prognostic assessment of patients with pulmonary embolism
pp. 2201-2207(7)
Authors: SÁNCHEZ, D.; De MIGUEL, J.; SAM, A.; WAGNER, C.; ZAMARRO, C.; NIETO, R.; GARCÍA, L.; AUJESKY, D.; YUSEN, R. D.; JIMÉNEZ, D.

Favourites:Add to Favourites

Free Content Long‐term follow‐up of patients with portal vein thrombosis and myeloproliferative neoplasms
pp. 2208-2214(7)
Authors: HOEKSTRA, J.; BRESSER, E. L.; SMALBERG, J. H.; SPAANDER, M. C. W.; LEEBEEK, F. W. G.; JANSSEN, H. L. A.

Favourites:Add to Favourites

Free Content Performance outcomes of a pharmacist‐managed anticoagulation clinic in the rural, resource‐constrained setting of Eldoret, Kenya
pp. 2215-2220(6)
Authors: MANJI, I.; PASTAKIA, S. D.; DO, A. N.; OUMA, M. N.; SCHELLHASE, E.; KARWA, R.; MILLER, M. L.; SAINA, C.; AKWANALO, C.

Favourites:Add to Favourites

Free Content A functional variant in the thrombospondin‐1 gene and the risk of small for gestational age infants
pp. 2221-2228(8)
Authors: ANDRAWEERA, P. H.; DEKKER, G. A.; THOMPSON, S. D.; NORTH, R. A.; McCOWAN, L. M. E.; ROBERTS, C. T.; ON BEHALF OF THE SCOPE CONSORTIUMcr7

Favourites:Add to Favourites

Free Content The use of a single von Willebrand factor‐containing, plasma‐derived FVIII product in hemophilia A immune tolerance induction: the US experience
pp. 2229-2234(6)
Authors: KURTH, M.; PUETZ, J.; KOUIDES, P.; SANDERS, J.; SEXAUER, C.; BERNSTEIN, J.; GRUPPO, R.; MANCO‐JOHNSON, M.; NEUFELD, E. J.; RODRIGUEZ, N.; WICKLUND, B.; QUON, D.; ALEDORT, L.

Favourites:Add to Favourites

Free Content Functional factor VIII made with von Willebrand factor at high levels in transgenic milk
pp. 2235-2242(8)
Authors: PIPE, S. W.; MIAO, H.; BUTLER, S. P.; CALCATERRA, J.; VELANDER, W. H.

Favourites:Add to Favourites

Free Content Increased tissue factor pathway inhibitor activity is associated with myocardial infarction in young women: results from the RATIO study
pp. 2243-2250(8)
Authors: WINCKERS, K.; SIEGERINK, B.; DUCKERS, C.; MAURISSEN, L. F.; TANS, G.; CASTOLDI, E.; SPRONK, H. M. H.; TEN CATE, H.; ALGRA, A.; HACKENG, T. M.; ROSENDAAL, F. R.

Favourites:Add to Favourites
Favourites:Add to Favourites

Free Content Activated protein C inhibitor for correction of thrombin generation in hemophilia A blood and plasma
pp. 2262-2267(6)
Authors: BRUMMEL‐ZIEDINS, K. E.; WHELIHAN, M. F.; RIVARD, G. E.; BUTENAS, S.

Favourites:Add to Favourites

Free Content TAFIa inhibiting nanobodies as profibrinolytic tools and discovery of a new TAFIa conformation
pp. 2268-2277(10)
Authors: HENDRICKX, M. L. V.; DE WINTER, A.; BUELENS, K.; COMPERNOLLE, G.; HASSANZADEH‐GHASSABEH, G.; MUYLDERMANS, S.; GILS, A.; DECLERCK, P. J.

Favourites:Add to Favourites

Free Content Extracellular protein disulfide isomerase regulates feedback activation of platelet thrombin generation via modulation of coagulation factor binding
pp. 2278-2290(13)
Authors: JURK, K.; LAHAV, J.; VAN AKEN, H.; BRODDE, M. F.; NOFER, J.‐R.; KEHREL, B. E.

Favourites:Add to Favourites

Free Content Genetic determinants of platelet reactivity during acetylsalicylic acid therapy in diabetic patients: evaluation of 27 polymorphisms within candidate genes
pp. 2291-2301(11)
Authors: POSTULA, M.; KAPLON‐CIESLICKA, A.; ROSIAK, M.; KONDRACKA, A.; SERAFIN, A.; FILIPIAK, K. J.; CZLONKOWSKI, A.; OPOLSKI, G.; JANICKI, P. K.

Favourites:Add to Favourites

Free Content Differences in platelet function in patients with acute myeloid leukemia and myelodysplasia compared to equally thrombocytopenic patients with immune thrombocytopenia
pp. 2302-2310(9)
Authors: PSAILA, B.; BUSSEL, J. B.; FRELINGER, A. L.; BABULA, B.; LINDEN, M. D.; LI, Y.; BARNARD, M. R.; TATE, C.; FELDMAN, E. J.; MICHELSON, A. D.

Favourites:Add to Favourites

Free Content Breast cancer chemotherapy induces the release of cell‐free DNA, a novel procoagulant stimulus
pp. 2313-2321(9)
Authors: SWYSTUN, L. L.; MUKHERJEE, S.; LIAW, P. C.

Favourites:Add to Favourites

Free Content Flow chamber‐based assays to measure thrombus formation in vitro: requirements for standardization
pp. 2322-2324(3)
Authors: ROEST, M.; REININGER, A.; ZWAGINGA, J. J.; KING, M. R.; HEEMSKERK, J. W. M.; the Biorheology Subcommittee of the SSC of the ISTHcr6

Favourites:Add to Favourites

Free Content Best evidence on B‐domain deletion and the immunogenicity of recombinant factor VIII
pp. 2325-2327(3)
Authors: ALEDORT, L. M.; NAVICKIS, R. J.; WILKES, M. M.

Favourites:Add to Favourites

Free Content Factor VIII inhibitors in previously treated hemophilic patients
pp. 2328-2329(2)
Author: MANNUCCI, P. M.

Favourites:Add to Favourites

Free Content Factor XII gene mutation in the Hageman family
pp. 2329-2331(3)
Authors: XU‐CAI, Y. O.; SHEN, J.; CHEN, S.; ZHOU, Y.; LARUSCH, G. A.; STAVROU, E.; SCHMAIER, A. H.; WU, Q.

Favourites:Add to Favourites

Free Content Join ISTH
pp. 2335-2336(2)

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more